Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Yearly Archives: 2023

You are here:
  1. Home
  2. 2023

Disclosure regarding the invitation to shareholders for the EGM

Regulatory DisclosuresBy adminJune 18, 2023

Disclosure to the EGX on the Organizational Structure

Regulatory DisclosuresBy adminJune 16, 2023

Disclosure regarding Rameda acquiring a selection of pharmaceutical products belong to diabetes and cholesterol treatment drugs

Regulatory DisclosuresBy adminJune 1, 2023

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. finalizes acquisition of a portfolio of 11 fast-growing cardiometabolic products

Corporate NewsBy adminJune 1, 2023

Rameda Reports its 1Q23 Results

Corporate NewsBy adminMay 15, 2023

Disclosure to EGX Regarding Issued and Paid-Up Capital

Regulatory DisclosuresBy adminMay 14, 2023

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminMay 14, 2023

Disclosure to EGX on AGM Minutes

Regulatory DisclosuresBy adminApril 18, 2023

Disclosure to the EGX on the Organizational Structure

Regulatory DisclosuresBy adminApril 5, 2023

Disclosure regarding the invitation to shareholders for the AGM

Regulatory DisclosuresBy adminMarch 9, 2023
←1234→

All Rights Reserved © 2024

Go to Top